Invasive Cardiology

Digital Edition

DIGITAL EDITION

Interactive BONUS content delivered to your email

CLICK HERE TO CONTINUE »





CLINICAL EVENTS CALENDAR

Non-Accredited Education

CLINICAL EXPERIENCE WITH A NEW HYBRID CORONARY WIRE
On Demand Web ArchiveNon-Accredited
Target Audience: Physicians, nurses, and technologists.
This activity is supported by an educational grant from Terumo Medical Corporation.

AVNRT Unmasking Asymptomatic ALCAPA (Anomalous Left Coronary Artery Arising from the Pulmonary Artery) with (FULL TITLE BELOW)




VOLUME: 22 PUBLICATION DATE: Feb 02 2010
Sidebars_in_article: 
Issue Number: 
2 (February 2010)
Start Page: 
32
End Page: 
33
author(s): 

AVNRT Unmasking Asymptomatic ALCAPA (Anomalous Left Coronary Artery Arising from the Pulmonary Artery) with Preserved Left Ventricular Function in Middle Age

Donah Zachariah, MBBS, MRCP, Paul R. Kalra, MA, MB BChir, FRCP,
Neil P. Andrews, B Med Sci, BMBS, DM, MRCP

ABSTRACT: We present the unusual case of a 49-year-old female with a previously undiagnosed anomalous left coronary artery arising from the pulmonary artery (ALCAPA) presenting in middle age with atrioventricular nodal reentry tachycardia (AVNRT) and preserved left ventricular function. She subsequently underwent successful translocation of her anomalous left coronary artery to the aorta.

J INVASIVE CARDIOL 2010;22:E32–E33

__________________________________________




Case Report. A 49-year-old female presented with a 3-hour history of palpitations associated with heaviness in her left arm. Examination revealed tachycardia at a rate of 250 beats per minute with a blood pressure of 137/93. Her electrocardiogram (ECG) confirmed a narrow complex tachycardia (Figure 1). Following 6 mg of intravenous adenosine, she had a run of nonsustained polymorphic ventricular tachycardia before reverting into sinus rhythm (Figure 2). A subsequent resting ECG showed T-wave inversion in lead aVL, but no other abnormality. Thyroid and renal functions were normal. Her troponin I was elevated at 3.34 µg/l (normal < 0.04 µg/l). Transthoracic echocardiography showed normal cardiac structure and function.

The patient’s medical history was significant for an event 10 years earlier when she collapsed in her general practitioner’s clinic following 2 days of continuous palpitations. She was found to be in ventricular fibrillation, and following serial DC cardioversions, she went into a rapid, regular narrow complex tachycardia, atrial fibrillation and subsequently sinus rhythm. On the basis of a normal exercise test and ambulatory ECG monitoring, the clinicians involved in her care at the time did not proceed to invasive evaluation; she was felt to have had an ischemic event leading to arrest and was discharged on aspirin, simvastatin and thyroxine. She did not have any subsequent history of chest pain or shortness of breath and remained completely fit and well with good exercise capacity until the current admission. She also has a past history of hypertension, hypothyroidism and Type 2 diabetes.

On this second presentation, cardiac catheterization was performed, which revealed a huge right coronary artery providing extensive collaterals to an anomalous left coronary artery arising from the main pulmonary artery (ALCAPA) with stenosis at the origin of the left main stem (Figures 3–5).

She underwent successful surgery with translocation of her anomalous left coronary artery to the aorta. Intra-operative findings confirmed severe left main stem stenosis. Electrophysiological studies subsequently revealed easily inducible atrioventricular nodal re-entry tachycardia (AVNRT). A slow pathway ablation was performed.

Discussion. ALCAPA is a rare congenital abnormality often associated with myocardial infarction, congestive heart failure and sudden death. Untreated mortality approaches 90% in infancy; without surgical correction; survival to adulthood in individuals with this coronary anomaly is extremely uncommon. This case is highly unusual in that at the age of 49, the patient’s left ventricular function was well preserved and she did not have ongoing cardiovascular symptoms. To our knowledge, there are only three reported cases of ALCAPA presenting in middle age or later with associated normal left ventricular function1–3 (one being an incidental autopsy finding). In our patient, we believe this is due to the huge right coronary artery providing a brisk collateral supply to the left coronary system. The presence of a significant left main stem stenosis at the vessel origin in the main pulmonary artery seen in this case may have facilitated myocardial perfusion, and by preventing rapid runoff of blood from the left coronary into the pulmonary artery, helped preserve left ventricular function.

In retrospect, initial presentation 10 years earlier with a cardiac arrest was likely secondary to a sustained tachyarrhythmia (probably AVNRT) resulting in myocardial ischemia and degeneration into ventricular fibrillation. Adenosine quite commonly induces brief, nonsustained ventricular tachycardia (NSVT) following successful chemical cardioversion of supraventricular tachycardia. However, in this case, the NSVT was polymorphic, rapid and longer than usual and was probably indicative of concurrent myocardial ischemia.

References

1. Fierens C, Budts W, Denef B, et al. A 72-year-old woman with ALCAPA. Heart 2000;83:E2.
2. Selzman CH, Zimmerman MA, Campbell DN. ALCAPA in an adult with preserved left ventricular function. J Card Surg 2003;18:25–28.
3. Leong SW, Borges AJ, Henry J, Butany J. Anomalous left coronary artery from the pulmonary artery: Case report and review of the literature. Int J Cardiol 2009;133:132–134.

________________________________________

From the Cardiology Department, Queen Alexandra Hospital, Portsmouth, United Kingdom.
The authors report no conflicts of interest regarding the content herein.

Manuscript submitted July 6, 2009, provisional acceptance given August 20, 2009, final version accepted August 26, 2009.

Address for correspondence: D. Zachariah, Cardiology Department, Queen Alexandra Hospital, Southwick Hill Rd, Portsmouth, PO6 3LY, United Kingdom. E-mail: donahez@hotmail.com

No votes yet


Post new comment

  • Web page addresses and e-mail addresses turn into links automatically.
  • Allowed HTML tags: <a> <em> <strong> <cite> <code> <ul> <ol> <li> <dl> <dt> <dd><br><h1><h2><h3><b><i>
  • Lines and paragraphs break automatically.

More information about formatting options


Cardiology Blogs

All Subscriptions are FREE to qualified cardiology professionals

#

  • Subscribe to:
  • Journal
  • Digital Journal
  • E-News
  • RSS feed

CLICK HERE TO CONTINUE »

Newly Revised and Updated for 2009!

practical EP



Press Release


FDA Clears Invatec's Mo.Ma Ultra Proximal Cerebral Protection Device

— Bethlehem, Pennsylvania – Invatec received 510(k) clearance from the U.S. Food and Drug Administration (FDA) in October to market its Mo.Ma Ultra Proximal Cerebral Protection Device for use during carotid artery stenting (CAS). The device effectively reduces and captures debris released during the stenting procedure to prevent it from traveling to the brain, where it has the potential to cause a stroke.


CME Showcase


The Use of Remote Robotic Navigation
in Complex Arrhythmias

Complimentary Accredited Web Archive
This activity is designed for electrophysiologists and EP allied professionals.

Diagnosing Coronary Artery Disease: Advanced Cardiovascular Imaging Solutions

Complimentary accredited web archive
This activity is intended for physicians, nurses, and technologists.



New Standards of Care for CRMD Antibiotic Protection
Complimentary CME Accredited Webcast
Dates: November 18, 2008 Time: 6:00 pm ET November 19, 2008 Time: 3:00 pm ET
This activity is sponsored by the North American Center for Continuing Medical Education.

REVIEW OUR OTHER
CARDIOLOGY BRANDS
Check out our other resources for healthcare professionals of all specialties.

  • CathLab Digest
  • EP Lab Digest
  • Vascular Disease Management